Hugo Alexandre Mendes de Oliveira
University of Minho, Portugal
Biography
Hugo Oliveira is a Senior Researcher at the University of Minho with 14 years of experience in bacteriophage biotechnology. His work focuses on advancing phage therapy to combat antimicrobial resistance. Since completing his PhD (2010–2014), he has specialized in the isolation and characterization of therapeutic bacteriophages and phage-derived antibacterial proteins, integrating microbiology, virology, genomics, molecular biology, and bioinformatics. He is currently dedicated to building well-characterized bacteriophage collections targeting priority pathogens for therapeutic and biocontrol applications, aiming to translate phage-based products into clinical and market use. His contributions include a patented phage-derived product licensed to industry, coordination of the Biofago project to develop a therapeutic phage cocktail, and involvement in national and European initiatives supporting the implementation of bacteriophage therapy in Portugal, where clinical trials have recently been authorized.
Tentative Title:
Advancing Personalized Phage Therapy in Portugal: Clinical Implementation and Rational Phage Cocktail Development
Pillar and Topic/Subtopic:
PILLAR 1: FRONTIERS HEALTH & CLINICAL INNOVATIONS
1.2: Antimicrobials & Resistance
